Dr Helen Jenkinson
Consultant Paediatric Oncologist
Dr Jenkinson looks after all the children referred to and managed by the retinoblastoma service and manages their chemotherapy jointly with paediatric oncology centres around the UK. Her retinoblastoma care is based in the Eye Department and the Oncology clinic.
She is also the Clinical lead for the Late Effects Multidisciplinary team and has a major role in the care of long-term survivors of childhood cancer both in the out-patient Oncology clinic (for under 18’s) and in the Adult Late Effects Clinic at University Hospital Birmingham (over 18s).
Dr Jenkinson’s local and national roles include being Chair of the Children's Cancer and Leukaemia Group (CCLG) Late Effects Core Discipline group, Chair of the CCLG Retinoblastoma special interest group, National Clinical Advisor to the National Cancer Survivorship Initiative (NCSI). She is also Chair of the West Midlands Regional Children’s Tumour Registry.
0121 333 8412
Professional and research interests
- Paediatric oncology
- Steering group member of the Cancer Research UK funded British Childhood Cancer Survivor Study (BCCSS) the largest epidemiology study into survivorship in the UK
- Co-researcher on the molecular genetic characterisation of RB study, led by Dr McConville
- Investigator on the BCCSS case-control studies into risks of adverse health outcomes in survivors of childhood cancer
- Childhood cancer survivors